| The international WAO/EAACI guideline for the management of hereditary angioedema–the 2017 revision and update M Maurer, M Magerl, I Ansotegui, E Aygören-Pürsün, S Betschel, K Bork, ... World Allergy Organization Journal 11, 1-20, 2018 | 884* | 2018 |
| 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema T Bowen, M Cicardi, H Farkas, K Bork, HJ Longhurst, B Zuraw, ... Allergy, Asthma & Clinical Immunology 6, 1-13, 2010 | 654 | 2010 |
| Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks TJ Craig, RJ Levy, RL Wasserman, AK Bewtra, D Hurewitz, K Obtułowicz, ... Journal of Allergy and Clinical Immunology 124 (4), 801-808, 2009 | 403 | 2009 |
| Hereditary angiodema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International Consensus Algorithm for the Diagnosis, Therapy, and Management of Hereditary … T Bowen, M Cicardi, K Bork, B Zuraw, M Frank, B Ritchie, H Farkas, ... Annals of Allergy, Asthma & Immunology 100 (1), S30-S40, 2008 | 289 | 2008 |
| Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial WR Lumry, HH Li, RJ Levy, PC Potter, H Farkas, D Moldovan, M Riedl, ... Annals of Allergy, Asthma & Immunology 107 (6), 529-537. e2, 2011 | 246 | 2011 |
| International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency H Farkas, I Martinez‐Saguer, K Bork, T Bowen, T Craig, M Frank, ... Allergy 72 (2), 300-313, 2017 | 214 | 2017 |
| Recombinant human C1-esterase inhibitor relieves symptoms of hereditary angioedema attacks: phase 3, randomized, placebo-controlled trial MA Riedl, JA Bernstein, H Li, A Reshef, W Lumry, D Moldovan, H Farkas, ... Annals of Allergy, Asthma & Immunology 112 (2), 163-169. e1, 2014 | 91 | 2014 |
| Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial MA Riedl, V Grivcheva-Panovska, D Moldovan, J Baker, WH Yang, ... The Lancet 390 (10102), 1595-1602, 2017 | 72 | 2017 |
| Efficacy and safety of recombinant human C1‐inhibitor for the treatment of attacks of hereditary angioedema: European open‐label extension study D Moldovan, A Reshef, J Fabiani, S Kivity, E Toubi, M Shlesinger, ... Clinical & Experimental Allergy 42 (6), 929-935, 2012 | 67 | 2012 |
| Psychometric field study of hereditary angioedema quality of life questionnaire for adults: HAE-QoL N Prior, E Remor, E Pérez-Fernández, M Caminoa, C Gómez-Traseira, ... The Journal of Allergy and Clinical Immunology: In Practice 4 (3), 464-473. e4, 2016 | 65 | 2016 |
| Recombinant human C1 inhibitor for the prophylaxis of hereditary angioedema attacks: a pilot study A Reshef, D Moldovan, K Obtulowicz, I Leibovich, E Mihaly, S Visscher, ... Allergy 68 (1), 118-124, 2013 | 49 | 2013 |
| Baseline level of functional C1-inhibitor correlates with disease severity scores in hereditary angioedema Z Kelemen, D Moldovan, E Mihály, B Visy, G Széplaki, D Csuka, G Füst, ... Clinical Immunology 134 (3), 354-358, 2010 | 48 | 2010 |
| Targeted next-generation sequencing for the molecular diagnosis of hereditary angioedema due to C1-inhibitor deficiency G Loules, M Zamanakou, F Parsopoulou, S Vatsiou, F Psarros, D Csuka, ... Gene 667, 76-82, 2018 | 44 | 2018 |
| C1‐INH concentrate for treatment of acute hereditary angioedema: a pediatric cohort from the IMPACT studies L Schneider, D Hurewitz, R Wasserman, K Obtulowicz, T Machnig, ... Pediatric allergy and immunology 24 (1), 54-60, 2013 | 43 | 2013 |
| Recombinant human-C1 inhibitor is effective and safe for repeat hereditary angioedema attacks HH Li, D Moldovan, JA Bernstein, A Reshef, G Porebski, M Stobiecki, ... The Journal of Allergy and Clinical Immunology: In Practice 3 (3), 417-423, 2015 | 42 | 2015 |
| Population pharmacokinetics of plasma-derived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacks JA Bernstein, B Ritchie, RJ Levy, RL Wasserman, AK Bewtra, ... Annals of Allergy, Asthma & Immunology 105 (2), 149-154, 2010 | 40 | 2010 |
| Icatibant for multiple hereditary angioedema attacks across the controlled and open-label extension phases of FAST-3 WR Lumry, H Farkas, D Moldovan, E Toubi, J Baptista, T Craig, M Riedl International Archives of Allergy and Immunology 168 (1), 44-55, 2015 | 39 | 2015 |
| Recombinant replacement therapy for hereditary angioedema due to C1 inhibitor deficiency D Moldovan, JA Bernstein, M Cicardi Immunotherapy 7 (7), 739-752, 2015 | 30 | 2015 |
| Preventing hereditary angioedema attacks in children using Cinryze®: interim efficacy and safety phase 3 findings E Aygören-Pürsün, D Soteres, D Moldovan, J Christensen, ... International archives of allergy and immunology 173 (2), 114-119, 2017 | 29 | 2017 |
| Clinical impact of peripheral attacks in hereditary angioedema patients A Kusuma, A Relan, AC Knulst, D Moldovan, B Zuraw, M Cicardi, RJ Levy, ... The American Journal of Medicine 125 (9), 937. e17-937. e24, 2012 | 28 | 2012 |
